INTRODUCTION
Protein 4.1R [1] is the prototypical member of a family of four highly paralogous proteins that include 4.1G (generally expressed) [2] , 4.1N (neuronal type) [3] and 4.1B (brain type) [4] . There are two major isoforms of 4.1R: the 135 kDa isoform (4.1R 135 ) and the 80 kDa isoform (4.1R 80 ) which lacks the HP (headpiece) region [5, 6] . We previously reported that both 4.1R 135 and 4.1R 80 isoforms interact with cytoplasmic domains of GPC (glycophorin C) [7] , band 3 [8] and CD44 [9] , and with p55 [10, 11] , and that the 30 kDa domain of the proteins is responsible for these interactions. Interestingly, we noted that the interaction of 4.1R 135 with GPC was an order of magnitude weaker than that of 4.1R 80 , whereas its interaction with band 3 was an order of magnitude stronger [12] , indicating possible regulation of the interactions by the HP region. 4.1G and both isoforms of 4.1R are expressed in erythroblasts during terminal differentiation [13] , but only 4.1R 80 is present in mature erythrocytes. Although the function of 4.1R isoforms in erythroid cells has been well characterized [12, 14] , there is little or no information on the function of 4.1G in these cells. The primary structure of 4.1G is very similar to that of 4.1R 135 ( Figure 1 ). The primary amino acid sequence of the 30 kDa FERM (4.1, ezrin, radixin, moesin) domain of 4.1G is 71 % identical with that of 4.1R. 4.1G is therefore predicted to bind to many of the 4.1R-binding partners described above. In contrast with the high conservation of the 30 kDa domains, the amino acid sequence identity of the HP region of 4.1G and 4.1R 135 is quite low (35 %). We hypothesize that the HP region may confer some distinct binding properties on the 30 kDa domain of 4.1G.
CaM (calmodulin) binds to both isoforms of 4.1R. Although its binding to 4.1R 80 was Ca 2+ -independent [15] , its binding to 4.1R 135 was strongly Ca 2+ -dependent [12] . Ca 2+ -saturated CaM completely inhibited the binding of 4.1R 135 to GPC and markedly reduced the affinity of its binding to band 3 [12] . The 4.1R 135 has three CaM-binding sites: a Ca 2+ -dependent site in the HP region and two sites in the 30 kDa domain [12, 14, 15] . The two CaMbinding sites in the 30 kDa domain are conserved in 4.1G and 4.1R. The sequence motif S 76 RGLSRLFSSFLKRPKS in the HP of 4.1R 135 is responsible for Ca 2+ -dependent CaM binding [16] . There is a similar sequence, S 71 RGISRFIPPWLKKQKS, in the HP of 4.1G. The questions thus arise as to whether CaM binds to all three site(s) and which site(s) would be essential for the Ca 2+ -dependent regulation of 4.1G binding to membrane proteins through CaM binding.
In the present study, we performed detailed characterization of the interaction of various erythroid membrane proteins with 4.1G and the regulation of these interactions by Ca 2+ and CaM.
Abbreviations used: CaM, calmodulin; CBB, Coomassie Brilliant Blue; EPO, erythropoietin; FBS, fetal bovine serum; FERM, 4.1, ezrin, radixin, moesin; GPC, glycophorin C; GST, glutathione transferase; HP, headpiece; IL, interleukin; IOV, inside-out vesicle; 2-ME, 2-mercaptoethanol; PI, photometric intensity; RMD, resonant mirror detection; SCF, stem cell factor; SEC, size-exclusion chromatography; SFEM, serum-free expansion medium; TBS, Tris-buffered saline. 1 To whom correspondence should be addressed (email takakuwa@research.twmu.ac.jp). . The HP is also referred to as unique region 1 (U1) whereas the 16 kDa domain between the 30 kDa domain and the SAB, and the domain between the SAB and the CTD are referred to as unique region 2 (U2) and 3 (U3) respectively. The apparent molecular masses of the SAB and CTD are 10 kDa and 22/24 kDa based on the migration of fragments obtained after α-chymotryptic digestion of 4.1R 80 [1] . The GenBank ® accession number for human 4 
MATERIALS AND METHODS

Reagents
The pET31b(+) bacterial expression vector was purchased from Novagen. pGEX-4T2 and pGEX-6P2 bacterial expression vectors, glutathione-Sepharose 4B, CaM-Sepharose 4B, heparinSepharose CL-6B, Q-Sepharose, Sephacryl S-200 and Sephacryl S-300 were purchased from GE Healthcare. Restriction enzymes were purchased from New England BioLabs. SFEM (serumfree expansion medium), FBS (fetal bovine serum), SCF (stem cell factor), IL (interleukin)-3 and EPO (erythropoietin) were purchased from Stemcell Technologies. All other reagents were purchased from Wako Pure Chemical Industries and SigmaAldrich unless noted otherwise. IAsys ® cuvettes coated with aminosilane were supplied by Affinity Sensors. CaM was purified as described previously [9] .
Antibodies
Polyclonal antibodies against 4.1G, 4.1R exon 2 and 4.1R exon 13 were raised in rabbit using His-tagged recombinant 4.1G HP, synthetic 4.1R exon 2 and exon 13 peptides as antigens. The antibodies were affinity-purified on Sulfolink Coupling Gel (Thermo Fisher Scientific). The HRP (horseradish peroxidase)-conjugated anti-rabbit immunoglobulins used for immunoblot analysis were purchased from Dako. The specificity of each antibody was confirmed by Western blotting on recombinant fulllength protein 4.1 isoforms, on tissues taken from the cognate knockout mice as negative controls [17] .
Computational analysis of structures of the HP and 30 kDa domain
The disorder probability for the structure of each domain was calculated using the PrDOS software package (http://prdos.hgc.jp) [18] . Their secondary structure was predicted by the PAPIA software package (http://mbs.cbrc.jp/papia/). The three-dimensional structure of the 4.1G 30 kDa domain was predicted by multiple alignment using the Modeller TM software (http://salilab.org/modeller/) based on the structure of the 30 kDa domains of 4.1R (PDB code 1GG3, chainA) and 4.1B (PDB code 2HE7). The 50 potential models obtained were ranked based on evaluation function [19] . The secondary structure and corresponding amino acid sequence of FERM domains were drawn using software package DSSP (http://swift.cmbi.ru.nl/gv/dssp/) [20] .
Preparation of recombinant human 4.1G and 4.1R proteins
Recombinant proteins corresponding to various combinations of the HP region of 4.1G (GHP), the 4.1G 30 kDa domain (G30) and the 4.1R 30 kDa domain (R30) were expressed as GST (glutathione transferase)-fusion proteins in Escherichia coli BL21(DE3). They included recombinant proteins corresponding to the HP and 30 kDa domains of 4.1G (GHP-G30) and to the chimaeric protein RHP-G30 (Figure 1 ). Preparation of recombinant 4.1R 135 has been described previously [12] . A 40 ml bacterial suspension in lysis buffer [50 mM Tris/HCl (pH 8.0) containing 200 mM NaCl, 1 mM EDTA, 1 mM 2-ME (2-mercaptoethanol), 1 mM benzamidine, 2 mM PMSF, 2 mM NaF and 0.5 % Triton X-100] was sonicated at 10 kHz (50 % power out) for 5 min on ice using an ultrasonic homogenizer (Smurt NR-50M, Microtec Nition). After sonication, bacterial lysates were loaded on to a glutathione affinity column to purify GST-fusion proteins. Recombinant proteins were eluted from the column after cleavage of the GST tag with thrombin as described previously [9] . After desalting, proteins were further purified on heparin-Sepharose equilibrated with 50 mM Tris/HCl (pH 7.5) containing 200 mM NaCl, 1 mM EDTA and 1 mM 2-ME and Sephacryl S-300 for GHP-G30 and Sephacryl S-200 for G30 to remove contaminants and breakdown products. Sephacryl S-300 and Sephacryl S-200 were equilibrated with 50 mM Tris/HCl (pH 7.5) containing 500 mM NaCl, 1 mM EDTA, 1 mM 2-ME, 2 mM NaF and 1 % glycerol (buffer A). The retention time is recorded by Akta Prime TM Plus (GE Healthcare). The purity of recombinant proteins was assessed by SDS/PAGE and Western blot analysis. Preparations of p55 and the cytoplasmic domains of band 3 (band 3cyt), GPC (GPCcyt) and CD44 (CD44cyt), have been described previously [9, 11, 15] . Protein concentrations were determined as described previously [9] .
Cloning of the HP, 30 kDa domain and chimaeric constructs
Human RHP, R30, GHP and G30 were cloned using 5 -NsiI-XhoI-3 sites into the pET31b(+) vector or 5 -EcoRI-XhoI-3 sites into the pGEX-4T2 vector. Full-length human 4.1G was cloned using 5 -EcoRI-SalI-3 sites into the pGEX-6P2 vector (the internal SalI site in the human 4.1G coding sequence being mutated prior to cloning without altering the amino acid sequence of the protein). A chimaeric protein corresponding to RHP and G30 (RHP-G30) was generated by the 'sewing method'. Briefly, the RHP was amplified with a forward primer (primer A: 5 -TCCA-GGAATTCCCATGACAACAGAGAAGAGTTTAGTGACTGA-GGC-3 ) creating an EcoRI site (underlined) upstream of the ATG initiation site of 4.1R (bold) and a reverse primer (primer B': 5 -TACTAAGAGGGTCACTTTACACTGGACGTTCCTGTGTTT-TCTGATTGGTTTTTGGGAAG-3 ) containing the end of RHP and the beginning of the G30 (italics). In a similar fashion, G30 was amplified with a forward primer (primer B: 5 -TC-CCAAAAACCAATCAGAAAACACAGGAACGTCCAGTGT -AAAGTGACCCTCTTAGAT-3 ) complementary to the reverse primer B' described above and a reverse primer (primer C: 5 -GTTCCGCTCGAGTCAAAATTTGGACCCCAAGGTCAGG -AACTTG-3 ) corresponding to the end of the G30 coding sequence followed by a stop codon (bold) and a XhoI site (underlined). The two PCR products were then mixed in equal amounts and subjected to a second amplification using primers A and C. The ∼ 1.5 kb chimaeric PCR product was digested with EcoRI-XhoI and cloned into the pGEX-4T2 vector. All constructs were checked by DNA sequencing (Elim BioPharmaceuticals) prior to expression in bacteria or mammalian cell transfection. The GenBank ® accession numbers for nucleotide sequences of human 4.1R and 4.1G are BC039079 and AF027299 respectively.
Preparation of IOVs (inside-out vesicles) and binding assay
IOVs depleted of all peripheral proteins were prepared using the method of Danilov et al. [21] with minor modifications [22] . The pelleting assay has been described previously [12] . Briefly, various concentrations of G30 and GHP-G30 were incubated for 14 h at 5
• C with IOVs in TBS [Tris-buffered saline: 50 mM Tris/HCl (pH 7.5), containing 150 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA, 2 mM NaF and protease inhibitors (Complete ® , Roche Diagnostics)]. The mixture of G30 and IOVs were laid on 150 μl of 3.3% sucrose cushion equilibrated in TBS. The sample was centrifuged at 60 000 rev./min for 20 min at 4
• C in a TL-100 ultracentrifuge using a TLA-100 rotor (Beckman Coulter). The supernatant and pellet were collected, treated with sample buffer and subjected to SDS/PAGE, using 12 % and 8.4 % gels for G30 and GHP-G30 respectively. Proteins bound to IOVs were visualized on CBB (Coomassie Brilliant Blue) G250 (Gelcode Blue ® , Pierce)-stained gels. Bound GHP-G30 to IOVs was analysed by immunoblot. The PI (photometric intensity) of bound proteins was analysed with a ChemiDoc XRS Plus ® (Bio-Rad Laboratories). The PI values of corresponding bands were plotted against the concentration of added proteins. An apparent dissociation constant at equilibrium estimated from the pelleting assay is represented as K . The results are presented as means + − S.D. calculated from three different measurements.
Purification of non-tagged full-length 4.1G
Bacteria expressing full-length recombinant human 4.1G were sonicated in 50 mM Tris/HCl (pH 8.0), 200 mM NaCl, 1 mM EDTA, 2 mM EGTA, 1 mM 2-ME, 1 mM benzamidine, 1 mM PMSF and 1 mM di-isopropylfluorophosphate on ice. The bacterial lysate was desalted stepwise by saturation with 35-50 % ammonium sulfate. The 35-50 % fraction containing 4.1G was dialysed against 50 mM Tris/HCl (pH 8.0), 1 mM EDTA, 1 mM 2-ME (buffer B) then loaded on to a Q-Sepharose column (1 cm × 29 cm, flow rate 0.7 ml/min) pre-equilibrated with buffer B. Protein elution, monitored by absorbance at 280 nm (A 280 ), was achieved with a linear gradient of NaCl (0 -500 mM) in buffer B. The fractions enriched in 4.1G (eluted with 320 mM NaCl) were further purified on a CaM-Sepharose column to remove the ∼ 50 kDa contaminant protein.
Binding analysis using CaM-Sepharose 4B
Full-length 4.1G and GHP were dialysed against 50 mM Tris/HCl (pH 7.5), 100 mM NaCl and 1 mM CaCl 2 (buffer C). Protein samples were loaded on to a 1.6 cm × 8 cm CaM-Sepharose 4B column pre-equilibrated with buffer C and run at a flow rate of 0.2 ml/min. The column was washed with an excess of buffer C until the A 280 returned to the baseline level. Bound proteins were eluted with buffer C supplemented with 500 mM NaCl or 50 mM Tris/HCl (pH 7.5), 100 mM NaCl and 5 mM EGTA.
RMD (resonant mirror detection) binding assays
Protein-protein interactions and protein-peptide interactions were measured using the IAsys ® based on the RMD method (Affinity Sensors) [23] . Below, the protein or peptide immobilized on the cuvette is referred to as the 'ligand', whereas the protein added in solution to the cuvette is referred to as the 'analyte'. Protein and peptide immobilization on aminosilane cuvettes has been described previously [9] . All binding assays were carried out at 25
• C with constant stirring. In experiments designed to quantify the effects of Ca 2+ and CaM on 4.1G and chimaeric protein binding profiles, full-length recombinant 4.1G (50 nM-1 μM) was pre-incubated with 5 μM CaM in 50 mM Tris/HCl (pH 7.5) and 100 mM NaCl (buffer D), and either 0.1 mM EGTA or 1.1 mM CaCl 2 and 1.0 mM EGTA at 25
• C for 30 min prior to binding assays with immobilized GPCcyt, band 3cyt, CD44cyt and p55 [9, 11, 15] .
The kinetic analysis and the stoichiometry of analyte binding to ligand were calculated according to previously published equations [9, 24] . In brief, a dissociation constant [termed 'K (D) '] was calculated as
where k a is the association rate constant and k d is the dissociation rate constant. The K (D) was obtained from the means of three to five measurements for k a and k d . The K (D) was confirmed by Scatchard plotting using the maximum binding value (B max ) and the added molar concentrations of analyte. The B max was calculated from the binding profile using the software package Fastfit ® version 2.1. The method for estimation of binding ratios has been described previously [15] . The B max of GHP-G30 represented as arc seconds was obtained from the Scatchard plot as described previously [15] . The amount of immobilized CaM on the aminosilane cuvette was determined as the difference of arc seconds between bis(sulfosuccinimidyl)suberate and CaM under equilibrium conditions. The stoichiometry of GHP-G30 binding to CaM was calculated according to the equation below described in the Method Guide of the IAsys ® system. Stoichiometry of GHP-G30: CaM = (B max of GHP-G30/58892): (amount of immobilized CaM on aminosilane cuvette/16705), where 58892 and 16705 are apparent molecular masses (in Da) of GHP-G30 and CaM respectively. The cuvettes were re-used after cleaning with 20 mM HCl. Original binding curves could be replicated after HCl washes implying that the washing procedure did not denature the bound ligands. In vitro culture of erythroblasts CD34 + HSC (haematopoietic stem cell) precursor cells were purified from cord blood (permission and approval to use cord blood was from the New York Blood Center) by Percoll separation followed by a CD34 MicroBead ® kit (Miltenyi Biotec). Cells were cultured using a two-phase culture system with modifications. In the first phase (days 0-6), cells (10 5 cells/ml) were cultured for 3 days in SFEM supplemented with 10 % FBS in the presence of SCF (50 ng/ml), IL-3 (10 ng/ml), EPO (1 unit/ml), α-thioglycerol (60 μM), penicillin (100 units/ml) and streptomycin (100 μg/ml). On day 4, cells were diluted to a density of 10 5 cells/ml with fresh medium and the culture was continued for a further 3 days. In the second phase (days 7-13), cells were cultured at 10 5 cells/ml in SFEM medium supplemented with 30 % FBS in the presence of EPO, α-thioglycerol and penicillin/streptomycin. Cellular morphology was assessed by cytospin on a daily basis followed by May-Grünwald Giemsa staining and light microscopy. The vast majority of the cells were proerythroblasts on day 7 and orthochromatic erythroblasts on day 13.
Calculation of molecular mass and isoelectric point
Theoretical molecular masses and isoelectric points were calculated based on peptide amino acid sequences using the software package DNASIS ® (Hitachi). (Table 1) . Importantly, the binding affinities of 4.1G for band 3cyt and GPCcyt were different from those of 4.1R 135 . 4.1G interacted with band 3cyt with a much lower affinity [high K (D) value] than did 4.1R 135 , whereas it interacted with much higher affinity with GPCcyt. These differences were mainly derived from differences in the association rate constant k a . In contrast, both 4.1G and 4.1R 135 interacted with CD44cyt and p55 with similar affinities.
Binding affinities of G30 and GHP-G30 to these membrane proteins were very similar to those of full-length 4.1G, suggesting that 4.1G interacted with its binding partners primarily through the 30 kDa domain (G30) and GHP did not affect these binding interactions. This is in marked contrast with interactions of the 30 kDa domain of 4.1R (R30) which were significantly affected by RHP [14] , indicating that while RHP influences R30 binding to its partners, GHP has little influence on G30 binding to its partners. Interestingly, a recombinant chimaeric protein consisting of RHP and G30 (RHP-G30) showed similar binding affinities to G30 and GHP-G30 (results not shown) implying significant differences in the structure and function of RHP and GHP. It should be noted that neither GHP nor RHP bound to any of these membrane proteins.
To validate 4.1G binding to intact membranes, we assayed binding of G30 or GHP-G30 to IOVs prepared from erythrocyte membranes. Scatchard plot analysis showed that these proteins bound to IOVs in a saturable manner (Figure 2 ). The apparent K values for G30 and GHP-G30 binding to IOVs were 169 + − 67 nM and 207 + − 49 nM respectively. These values were similar to those obtained using RMD (Table 1 ). These findings demonstrate that 4.1G can bind to transmembrane proteins of the erythrocyte membrane through its 30 kDa domain. Calculation of the disorder probability of each domain was carried out based on PrDOS software analysis, a value greater than 0.5 reflecting a disordered structure, the probability of false prediction reaching only 5 %. This analysis predicted a highly disordered structure for the HP region (amino acids 1-209) and, as expected, a highly ordered structure for the 30 kDa domain (amino acids 210-507). Of particular note, whereas the overall HP region adopted a disordered structure, a polypeptide (amino acids 70-80), corresponding to a previously identified Ca 2+ -dependent CaM-binding site [16] , exhibited an ordered structure (Supplementary Figure  S2 at http://www.BiochemJ.org/bj/432/bj4320407add.htm). SDS/PAGE analysis and SEC (size-exclusion chromatography) (for reviews see [26] [27] [28] ) lent some indirect support for the structural prediction that the HP domain is an unfolded protein. The theoretical molecular mass of GHP is 23 kDa, but the apparent molecular mass was estimated as 36 kDa by SDS/PAGE, as shown in Figure 4 (C). Although the theoretical molecular masses of GHP-G30 and G30 are 57 kDa and 33 kDa respectively, they migrated as polypeptides of 75 kDa and 35 kDa respectively on SDS/PAGE (see Supplementary Figure S3 at http://www.BiochemJ.org/bj/432/bj4320407add.htm). Although we cannot rule out that the acidic nature of GHP could affect its binding to SDS, other acidic proteins with similar isoelectric points (5.3-5.6) such as BSA or GFAP (glial fibrillary acidic protein) show no increase in apparent molecular mass [29] . Furthermore, SEC analysis, employing Sephacryl S-300, showed that GHP-G30 was eluted between IgG (150 kDa) and albumin (68 kDa) (see Supplementary Figure S4 at http://www.BiochemJ.org/bj/432/bj4320407add.htm), further suggesting that GHP adopts an abnormal shape. Taken together, these findings suggest, but do not prove, that the GHP is an unfolded domain, whereas G30 is folded. PrDOS-based analysis of full-length 4.1G and 4.1R 135 also predicted that the 30 kDa domain was the only region in these full-length proteins than can adopt an ordered structure (results not shown).
4.1G binding to CaM in a Ca
2+ -dependent manner
We next investigated whether CaM binds to 4.1G in the absence and presence of Ca 2+ . Both full-length 4.1G and GHP bound to a CaM-Sepharose 4B column in the presence of Ca 2+ and could be eluted with 5 mM EGTA (Figure 4) . The K (D) for CaM binding to 4.1G and GHP increased dramatically following chelation of Ca 2+ with EGTA (Table 2 ). These findings established that CaM bound to the HP region of 4.1G in a Ca 2+ -dependent manner. These data recapitulated previous observations made for CaM binding to RHP and 4.1R
135 [12] . In addition to the CaM-binding site in the HP region of 4.1G, two CaM-binding sites have been mapped in the 30 kDa domain, one of them being Ca 2+ -independent. Indeed, G30 alone bound to CaM in a Ca 2+ -independent manner, as did R30 alone [14, 15] (Table 2) . We therefore probed a recombinant 4.1G expressing both the HP region and 30 kDa domain (GHP-G30). Recombinant GHP-G30 protein behaved like full-length 4.1G, i.e. it bound to a CaM-Sepharose 4B column in the presence of Ca 2+ and was eluted in the presence of EGTA (results not shown). The K (D) for CaM binding to GHP-G30 increased dramatically in the presence of EGTA, as observed for full-length 4.1G (Table 2) . We also determined the stoichiometry of GHP-G30 binding to CaM using immobilized CaM in a IAsys ® system assay ( Figure 5 ). The binding ratio was calculated as (2.2/58892):(0.7/16800) = 1.1:1, where 2.2 arc seconds is the B max of GHP-G30, 0.7 arc seconds is the immobilized CaM concentration and 58892 Da and 16705 Da are the molecular masses of GHP-G30 and CaM respectively. The fact that the stoichiometry of binding of GHP-G30 and CaM is ∼ 1:1, implies that only one of the three potential CaM-binding sites in GHP-G30 is functional in 4.1G. It is to be noted that the chimaeric protein of RHP-G30 (where GHP is replaced with the RHP of GHP-G30) completely lost its ability to regulate G30 binding to CaM by Ca 2+ (Table 2) . This observation strongly supported the importance of GHP on the Ca 2+ -dependence of CaM binding to 4.1G.
Ca
2+ /CaM regulation of 4.1G binding to membrane proteins
In the light of these observations and our previous studies documenting Ca 2+ /CaM-dependent regulation of 4.1R binding to membrane proteins through its 30 kDa domain [12] , we examined the Ca 2+ /CaM-dependent regulation of 4.1G binding to its various binding partners. As shown in Table 3 , Ca 2+ /CaM binding to the HP of 4.1G resulted in complete inhibition of 4.1G binding to band 3cyt, CD44cyt and p55, and a significant increase in the K (D) for 4.1G binding to GPCcyt.
On the basis of the fact that CaM bound to the 30 kDa domain on 4.1R 80 in the absence of Ca 2+ and decreased K (D) for its binding partners in a Ca 2+ -dependent manner [14, 15] , we also examined the effect of CaM binding to G30 on its binding to membrane proteins using RHP-G30. Binding affinities of RHP-G30 for band 3cyt, GPCcyt, p55 and CD44cyt were measured in the presence or absence of Ca 2+ and CaM (Table 4) . The K (D) obtained for each binding partner in the absence of CaM was similar to that obtained with full-length 4.1G (Table 1 ). In contrast, binding assays performed with RHP-G30 pre-incubated with Ca 2+ /CaM showed a major decrease in binding affinity [7-10- CaM was immobilized on an aminosilane cuvette. The binding assay was carried out in the presence of 1 mM Ca 2+ . The B max (arc seconds) at each GHP-G30 concentration was calculated using the software package Fastfit ® and B max is plotted against the ratio B max /concentration of added GHP-G30 (B max /GHP-G30). The maximum binding (B max ) at the crossing point on the x-axis was 2.4. The half-maximum binding occurred at 87 nM GHP-G30, an affinity that is similar to the K (D) value calculated from kinetic binding analysis (44 nM, Table 2 ). The open circle represents the B max in the absence of Ca 2+ . were regulated by CaM in a Ca 2+ -dependent manner. The RHP-G30 indeed co-pelleted with IOVs (see Supplementary Figure S5 at http://www.BiochemJ.org/bj/432/bj4320407add.htm).
The Ca 2+ -concentration-dependence of the CaM-modulated interaction of GHP-G30 with band 3cyt and GPCcyt was measured (Figure 6 ). At Ca 2+ concentrations greater than 0.01 μM (pCa = 8), the extent of GHP-G30 binding to band 3cyt and GPCcyt started to decline, and maximal inhibition of the binding was noted at Ca 2+ concentrations of 100 μM and higher (pCa = 4). A half-maximal effect was seen at a Ca 2+ concentration of ∼ 0.1 μM (pCa = 7). In the absence of CaM, the binding affinities were not altered (results not shown). 
Expression of 4.1G and 4.1R 135 in human erythroblasts
To establish the biological significance of our biochemical findings, we studied the expression pattern of 4.1G and 4.1R 135 during terminal differentiation of human erythroblasts ( Figure 7 ). Western blot analysis using antibodies specific for 4.1R and 4.1G showed that both 4.1G and 4.1R 135 were highly expressed in proerythroblasts (day 7 of culture), but their expression level was markedly decreased in orthochromatic erythroblasts (day 13 of culture). In contrast, the expression level of 4.1R 80 that was low in proerythroblasts was markedly elevated in orthochromatic erythroblasts.
DISCUSSION
In the present study, we demonstrated that 4.1G binds through its 30 kDa domain to various previously defined binding partners for 4.1R, including transmembrane proteins such as band 3, GPC, CD44 and p55. These interactions were not affected by the HP region, but Ca 2+ -dependent CaM binding to the HP region had a profound effect on the interaction of 4.1G with its binding partners. The documented binding profiles of 4.1G are markedly different from that previously reported for 4.1R
135 [12] . Since the primary structure of the 30 kDa domain of 4.1G and 4.1R is highly conserved (71 % sequence identity), the differences in binding profiles arise primarily from the non-conserved HP region. We provide here extensive support for this hypothesis through the use of several recombinant proteins, GHP, G30 and GHP-G30, as well as the chimaeric protein RHP-G30.
Computational calculation indicates that the three-dimensional structure of the 30 kDa domain of 4.1G is very similar to that of 4.1R, a clover-like structure adopting a globular conformation [30] . The high similarity of three-dimensional structure is supported by in vitro binding assays. Strikingly, the binding sites for each major binding partner of this domain are located on a different lobe of the clover-like structure [26] : band 3 on the Nlobe [31] , GPC on the α-lobe [11] and p55 [11] and CD44 on the C-lobe [32] . We previously showed an important role for the HP region in regulating 4.1R 135 30 kDa domain binding to membrane proteins [12] ; the HP region itself improved accessibility of the N-lobe to band 3, impaired accessibility of the α-lobe to GPC and did not have much influence on the C-lobe [12] . In contrast, 135 . The present study highlights that GHP-G30 and RHP-G30 represent unique structural and functional modules, despite the high amino acid sequence identity of their 30 kDa domains and the conservation of CaM-binding sites. Delineation of the structure of the HP region alone and in combination with the 30 kDa domain will be critical for validating these hypotheses.
The present results indicate that CaM bound to the HP region of 4.1G in a Ca 2+ -dependent manner, but not to the 30 kDa domain as has been previously documented for 4.1R 80 [15] . The HP region of 4.1G contains the sequence S 71 RGISRFIPPWLKKQKS which is 76 % identical (13 out of 17 residues) with the CaM-binding site in the HP region of 4.1R (S 76 RGLSRLFSSFLKRPKS) [12, 16] . Although the Ca 2+ -independent CaM-binding sequence previously identified in the 30 kDa domain of 4.1R 80 is also conserved in 4.1G [15] , our findings imply that CaM binds to the HP region, but not to the 30 kDa domain of 4.1G. It should be emphasized that although the HP by itself does not affect the binding to the 30 kDa domain of 4.1G to various membrane proteins, Ca 2+ /CaM binding to the HP markedly inhibits the ability of 4.1G to interact with its various binding partners. These findings have enabled us to document similarities and differences in the structural and functional properties of 4.1G and 4.1R 135 . Our finding that the half-maximal binding of GHP-G30 to band 3cyt and GPCcyt occurred at Ca 2+ concentrations in the submicromolar range suggests potential biological relevance of our biochemical findings. Ca 2+ /CaM modulations of 4.1G binding to membrane proteins may be modulated upon signal transduction during erythroid development, since at early stages of erythropoiesis it has been documented that, following binding of EPO to its receptor, intracellular Ca 2+ levels increased to 259 + − 49nM from a basal level of 55 + − 5nM [33, 34] . This level of increase in intracellular Ca 2+ levels is sufficient to modulate the interaction of 4.1G with its binding partners in erythroid cells.
Our findings further suggest that 4.1G offers a unique opportunity to explore divergence of protein structure and function during evolution and development. In erythroblasts, we showed that 4.1G and 4.1R 135 are both expressed during terminal erythroid differentiation consistent with an earlier report [13] , and both of these proteins can interact with the transmembrane proteins band 3, GPC and CD44. Different binding affinities and Ca 2+ /CaM modulation to band 3 and GPC suggest that these 4.1 proteins may play specific roles in membrane biogenesis during terminal erythroid differentiation.
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